Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 5/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ether SCHEMBL2816206 | 0.98 | ELANE (0.55) | ELANEKMT2AATMTHRBMAPT | |
| Ether SCHEMBL4565300 | 0.95 | ELANE (0.61) | ELANEKMT2AATMTHRBMAPT | |
| Ether SCHEMBL1684011 | 0.95 | ELANE (0.61) | ELANEKMT2AATMTHRBMAPT | |
| Di(Hydroxyethyl)Ether SCHEMBL22164296 | 0.93 | ELANE (0.52) | ELANEKMT2AATMTHRBMAPT | |
| Ethylene Glycol SCHEMBL11505950 | 0.92 | ELANE (0.65) | ELANEKMT2AATMMAPTALDH1A1 | |
| Tetraethylene Glycol SCHEMBL22164293 | 0.91 | ELANE (0.51) | ELANEKMT2AATMTHRBMAPT | |
| Alcohol SCHEMBL22362243 | 0.89 | ELANE (0.65) | ELANEKMT2AATMMAPTALDH1A1 | |
| Alcohol SCHEMBL29060500 | 0.87 | ELANE (0.63) | ELANEKMT2AATMMAPTALDH1A1 | |
| Propane SCHEMBL6908233 | 0.87 | ELANE (0.67) | ELANEKMT2AATMMAPTALDH1A1 | |
| Di(Hydroxyethyl)Ether SCHEMBL10489041 | 0.86 | ELANE (0.58) | ELANEKMT2AATMTHRBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 672 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042870-A1 | BINDER COMPOSITIONS AND USES THEREOF | KNAUF INSULATION SPRL (BE) | 2026-02-12 | — | — | US | claimed |
| EP-3247328-B1 | METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS | GENEVANT SCIENCES GMBH (CH) | 2026-01-07 | — | — | EP | claimed |
| WO-2025198684-A9 | BaTiO3 NANOCRYSTALS AND NANOCOMPOSITES | PIXELLIGENT TECHNOLOGIES LLC (US) | 2025-11-27 | — | — | WO | claimed |
| US-12466899-B2 | Binder compositions and uses thereof | KNAUF INSULATION SPRL (BE) | 2025-11-11 | — | — | US | claimed |
| US-20250230334-A1 | SOLVENT-FREE FORMULATIONS AND NANOCOMPOSITES | PT SPE SUBCO LLC (US) | 2025-07-17 | — | — | US | claimed |
| US-20250198980-A1 | COMBINATORIAL HIGH-THROUGHPUT SCREENING OF COMPLEX POLYMERIC ENZYME IMMOBILIZATION SUPPORTS | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2025-06-19 | — | — | US | claimed |
| CN-119978218-A | Multi-stimulus response type photon film display material, preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2025-05-13 | — | — | CN | claimed |
| US-12286549-B2 | Solvent-free formulations and nanocomposites | PT SPE SUBCO LLC (US) | 2025-04-29 | — | — | US | claimed |
| CN-115066288-B | Method for coupling ligands to composite materials | 默克密理博有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-118853041-A | Preparation method and product of lithium ion energy storage battery negative electrode SBR binder | 苏州德比电子材料科技有限公司 | 2024-10-29 | — | — | CN | claimed |
| US-20130021554-A1 | LIQUID CRYSTAL DISPLAY DEVICE INCLUDING SIDE SUPPORTING MEANS AND METHOD OF FABRICATING THE SAME | LG DISPLAY CO., LTD (KR) | 2013-01-24 | — | — | US | claimed |
| WO-2012037101-A2 | CHROMATOGRAPHY MEMBRANES FOR THE PURIFICATION OF CHIRAL COMPOUNDS | NATRIX SEPARATIONS INC. (CA) | 2012-03-22 | — | — | WO | claimed |
| US-20120064601-A1 | Chromatography Membranes for the Purification of Chiral Compounds | NATRIX SEPARATIONS INC. (CA) | 2012-03-15 | — | — | US | claimed |
| WO-2008106323-A2 | A HIGH THROUGHPUT SCREENING METHOD AND APPARATUS TO PRODUCE MODIFIED POLYMERS PARTICULARLY MEMBRANES | RENSSELAER POLYTECHNIC INSTITUTE (US) | 2008-09-04 | — | — | WO | claimed |
| US-7297727-B2 | Triarylsilyl(meth)acryloyl-containing polymers for marine coating compositions | ARKEMA INC. (US) | 2007-11-20 | — | — | US | claimed |
| EP-1479737-B1 | Triarylsilyl(meth)acryloyl-containing polymers for marine coating compositions | ARKEMA INC (US) | 2006-08-16 | — | — | EP | claimed |
| EP-1479737-A1 | Triarylsilyl(meth)acryloyl-containing polymers for marine coating compositions | Atofina Chemicals, Inc. (US) | 2004-11-24 | — | — | EP | claimed |
| US-20040138332-A1 | Triarylsilyl(meth)acryloyl-containing polymers for marine coating compositions | ARKEMA INC. | 2004-07-15 | — | — | US | claimed |
| US-20030225184-A1 | Triarylsilyl(meth)acryloyl-containing polymers for marine coating compositions | ARKEMA INC. | 2003-12-04 | — | — | US | claimed |
| EP-1367100-A1 | Triarylsilyl (meth) acryloyl-containing polymers for marine coating compositions | ATOFINA CHEMICALS, INC. (US) | 2003-12-03 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042870-A1 | BINDER COMPOSITIONS AND USES THEREOF | SMCHD1, VCL, FGB | ELANE 3174/4885KMT2A 2106/4885ATM 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.